Page 59 - Revista SPORL - Vol 59. Nº2

radiology.193.1.8090883.
7. Ichimiya Y, Alluri K, Marcus C, Best S. et al. Imaging modality
utilization trends in patients with stage III-IV oropharyngeal squamous
cell carcinoma. Am J Nucl Med Mol Imaging. 2015 Jan 15;5(2):154-
61. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4396006/pdf/ajnmmi0005-0154.pdf
8. Yamazaki Y, Saitoh M, Notani K, Tei K. et al. Assessment of cervical
lymph node metastases using FDG-PET in patients with head and neck
cancer. Ann Nucl Med. 2008 Apr;22(3):177-84. doi: 10.1007/s12149-
007-0097-9.
9. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH. et al. New
response evaluation criteria in solid tumours : Revised RECIST
guideline (version 1.1). Eur J Cancer. 2009 Jan;45(2):228-47. doi:
10.1016/j.ejca.2008.10.026.
10. Helsen N, Van den Wyngaert T, Carp L, Stroobants S. FDG-PET /
CT for treatment response assessment in head and neck squamous
cell carcinoma: a systematic review and meta-analysis of diagnostic
performance. Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):1063-
1071. doi: 10.1007/s00259-018-3978-3.
11. Mehanna H, Wong WL, McConkey CC, Rahman JK. et al. PET-CT ARTIGO ORIGINAL ORIGINAL ARTICLE
Surveillance versus Neck Dissection in Advanced Head and Neck
Cancer. N Engl J Med. 2016 Apr 14;374(15):1444-54. doi: 10.1056/
NEJMoa1514493.
12. Moeller BJ, Rana V, Cannon BA, Williams MD. et al. Prospective
Risk-Adjusted [18 F] Fluorodeoxyglucose Positron Emission
Tomography and Computed Tomography Assessment of Radiation
Response in Head and Neck. J Clin Oncol. 2009 May 20;27(15):2509-
15. doi: 10.1200/JCO.2008.19.3300.
13. Pryor DI, Porceddu SV, Scuffham PA, Whitty JA. et al. Economic
analysis of FDG-PET – guided management of the neck after primary
chemoradiotherapy for node-positive head and neck squamous
cell carcinoma. Head Neck. 2013 Sep;35(9):1287-94. doi: 10.1002/
hed.23108.
14. Martens RM, Noij DP, Ali M, Koopman T. et al. Functional imaging
early during (chemo) radiotherapy for response prediction in head
and neck squamous cell carcinoma; a systematic review. Oral Oncol.
2019 Jan;88:75-83. doi: 10.1016/j.oraloncology.2018.11.005.
15. Pollom EL, Song J, Durkee BY, Aggarwal S. et al. Prognostic value
of midtreatment FDG-PET in oropharyngeal cancer. Head Neck. 2016
Oct;38(10):1472-8. doi: 10.1002/hed.24454.
16. Greven KM, Williams DW 3rd, McGuirt WF Sr, Harkness BA. et
al. Serial positron emission tomography scans following radiation
therapy of patients with head and neck cancer. Head Neck. 2001
Nov;23(11):942-6. doi: 10.1002/hed.1136.
17. Leung AS, Rath TJ, Hughes MA, Kim S. et al. Optimal timing of
first posttreatment FDG PET/CT in head and neck squamous cell
carcinoma. Head Neck. 2016 Apr;38 Suppl 1:E853-8. doi: 10.1002/
hed.24112.
18. Gupta T, Master Z, Kannan S, Agarwal JP. et al. Diagnostic
performance of post-treatment FDG PET or FDG PET/CT imaging in
head and neck cancer: a systematic review and meta-analysis. Eur
J Nucl Med Mol Imaging. 2011 Nov;38(11):2083-95. doi: 10.1007/
s00259-011-1893-y.

VOL 59 . Nº2 . JUNHO 2021 137